These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 26554541)

  • 21. Coculture of osteoclast precursors with rheumatoid synovial fibroblasts induces osteoclastogenesis via transforming growth factor beta-mediated down-regulation of osteoprotegerin.
    Hase H; Kanno Y; Kojima H; Sakurai D; Kobata T
    Arthritis Rheum; 2008 Nov; 58(11):3356-65. PubMed ID: 18975335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of vascular endothelial growth factor on osteoclastogenesis in rheumatoid arthritis.
    Kim HR; Kim KW; Kim BM; Cho ML; Lee SH
    PLoS One; 2015; 10(4):e0124909. PubMed ID: 25894998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha.
    Dai SM; Nishioka K; Yudoh K
    Ann Rheum Dis; 2004 Nov; 63(11):1379-86. PubMed ID: 15479886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of FcRL4 defines a pro-inflammatory, RANKL-producing B cell subset in rheumatoid arthritis.
    Yeo L; Lom H; Juarez M; Snow M; Buckley CD; Filer A; Raza K; Scheel-Toellner D
    Ann Rheum Dis; 2015 May; 74(5):928-35. PubMed ID: 24431391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of systemic and intra-articular osteoclastogenic potential, pro-inflammatory mediators and disease activity with the form of inflammatory arthritis.
    Ikić M; Jajić Z; Lazić E; Ivčević S; Grubišić F; Marušić A; Kovačić N; Grčević D
    Int Orthop; 2014 Jan; 38(1):183-92. PubMed ID: 24100919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-15 promotes osteoclastogenesis via the PLD pathway in rheumatoid arthritis.
    Park MK; Her YM; Cho ML; Oh HJ; Park EM; Kwok SK; Ju JH; Park KS; Min DS; Kim HY; Park SH
    Immunol Lett; 2011 Sep; 139(1-2):42-51. PubMed ID: 21620893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promotion of osteoclastogenesis by IL-26 in rheumatoid arthritis.
    Lee KA; Kim KW; Kim BM; Won JY; Min HK; Lee DW; Kim HR; Lee SH
    Arthritis Res Ther; 2019 Dec; 21(1):283. PubMed ID: 31831038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor.
    Gravallese EM; Manning C; Tsay A; Naito A; Pan C; Amento E; Goldring SR
    Arthritis Rheum; 2000 Feb; 43(2):250-8. PubMed ID: 10693863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-23 induces receptor activator of NF-kappaB ligand expression in fibroblast-like synoviocytes via STAT3 and NF-kappaB signal pathways.
    Li X; Kim KW; Cho ML; Ju JH; Kang CM; Oh HJ; Min JK; Lee SH; Park SH; Kim HY
    Immunol Lett; 2010 Jan; 127(2):100-7. PubMed ID: 19900478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis.
    Takayanagi H; Iizuka H; Juji T; Nakagawa T; Yamamoto A; Miyazaki T; Koshihara Y; Oda H; Nakamura K; Tanaka S
    Arthritis Rheum; 2000 Feb; 43(2):259-69. PubMed ID: 10693864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synovial fluid macrophages are capable of osteoclast formation and resorption.
    Adamopoulos IE; Sabokbar A; Wordsworth BP; Carr A; Ferguson DJ; Athanasou NA
    J Pathol; 2006 Jan; 208(1):35-43. PubMed ID: 16278818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum RANKL levels associate with anti- citrullinated protein antibodies in early untreated rheumatoid arthritis and are modulated following methotrexate.
    Hensvold AH; Joshua V; Li W; Larkin M; Qureshi F; Israelsson L; Padyukov L; Lundberg K; Defranoux N; Saevarsdottir S; Catrina AI
    Arthritis Res Ther; 2015 Sep; 17(1):239. PubMed ID: 26337028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation mechanism of RANKL(+) effector memory B cells: relevance to the pathogenesis of rheumatoid arthritis.
    Ota Y; Niiro H; Ota S; Ueki N; Tsuzuki H; Nakayama T; Mishima K; Higashioka K; Jabbarzadeh-Tabrizi S; Mitoma H; Akahoshi M; Arinobu Y; Kukita A; Yamada H; Tsukamoto H; Akashi K
    Arthritis Res Ther; 2016 Mar; 18():67. PubMed ID: 26980135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential role and mechanism of IFN-gamma inducible protein-10 on receptor activator of nuclear factor kappa-B ligand (RANKL) expression in rheumatoid arthritis.
    Lee EY; Seo M; Juhnn YS; Kim JY; Hong YJ; Lee YJ; Lee EB; Song YW
    Arthritis Res Ther; 2011 Jun; 13(3):R104. PubMed ID: 21708014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human rheumatoid synovial fibroblasts promote osteoclastogenic activity by activating RANKL via TLR-2 and TLR-4 activation.
    Kim KW; Cho ML; Lee SH; Oh HJ; Kang CM; Ju JH; Min SY; Cho YG; Park SH; Kim HY
    Immunol Lett; 2007 May; 110(1):54-64. PubMed ID: 17467812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CXCL12 chemokine up-regulates bone resorption and MMP-9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients.
    Grassi F; Cristino S; Toneguzzi S; Piacentini A; Facchini A; Lisignoli G
    J Cell Physiol; 2004 May; 199(2):244-51. PubMed ID: 15040007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synovial membrane immunohistology in early-untreated rheumatoid arthritis reveals high expression of catabolic bone markers that is modulated by methotrexate.
    Revu S; Neregård P; af Klint E; Korotkova M; Catrina AI
    Arthritis Res Ther; 2013; 15(6):R205. PubMed ID: 24295447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IFN-gamma-producing human T cells directly induce osteoclastogenesis from human monocytes via the expression of RANKL.
    Kotake S; Nanke Y; Mogi M; Kawamoto M; Furuya T; Yago T; Kobashigawa T; Togari A; Kamatani N
    Eur J Immunol; 2005 Nov; 35(11):3353-63. PubMed ID: 16220542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RANKL expression in chondrocytes and its promotion by lymphotoxin-α in the course of cartilage destruction during rheumatoid arthritis.
    Takeshita A; Nishida K; Yoshida A; Nasu Y; Nakahara R; Kaneda D; Ohashi H; Ozaki T
    PLoS One; 2021; 16(7):e0254268. PubMed ID: 34234380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atorvastatin inhibits osteoclastogenesis by decreasing the expression of RANKL in the synoviocytes of rheumatoid arthritis.
    Kim JY; Lee EY; Lee EB; Lee YJ; Yoo HJ; Choi J; Song YW
    Arthritis Res Ther; 2012 Aug; 14(4):R187. PubMed ID: 22901757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.